Re-irradiation of recurrent IDH-wildtype glioblastoma in the bevacizumab and immunotherapy era: Target delineation, outcomes and patterns of recurrence

por Christ, Sebastian M., Youssef, Gilbert, Tanguturi, Shyam K., Cagney, Daniel, Shi, Diana, McFaline-Figueroa, J. Ricardo, Chukwueke, Ugonma, Lee, Eudocia Q., Hertler, Caroline, Andratschke, Nicolaus, Weller, Michael, Reardon, David A., Haas-Kogan, Daphne, Guckenberger, Matthias, Wen, Patrick Y., Rahman, Rifaquat
Publicado 2023

Molecular alterations of the IDH1 gene in AML: a Children’s Oncology Group and Southwest Oncology Group study

por Ho, Phoenix A., Alonzo, Todd A., Kopecky, Kenneth J., Miller, Kristen L., Kuhn, Julia, Zeng, Rong, Gerbing, Robert B., Raimondi, Susana C., Hirsch, Betsy A., Oehler, Vivian, Hurwitz, Craig A., Franklin, Janet L., Gamis, Alan S., Petersdorf, Stephen H., Anderson, Jeanne E., Reaman, Gregory H., Baker, Laurence H., Willman, Cheryl L., Bernstein, Irwin D., Radich, Jerald P., Appelbaum, Frederick R., Stirewalt, Derek L., Meshinchi, Soheil
Publicado 2010

A new sensitive PCR assay for one-step detection of 12 IDH1/2 mutations in glioma

por Catteau, Aurélie, Girardi, Hélène, Monville, Florence, Poggionovo, Cécile, Carpentier, Sabrina, Frayssinet, Véronique, Voss, Jesse, Jenkins, Robert, Boisselier, Blandine, Mokhtari, Karima, Sanson, Marc, Peyro-Saint-Paul, Hélène, Giannini, Caterina
Publicado 2014

Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma

por Pellegatta, Serena, Valletta, Lorella, Corbetta, Cristina, Patanè, Monica, Zucca, Ileana, Riccardi Sirtori, Federico, Bruzzone, Maria Grazia, Fogliatto, Gianpaolo, Isacchi, Antonella, Pollo, Bianca, Finocchiaro, Gaetano
Publicado 2015

The oncometabolite D-2-hydroxyglutarate induced by mutant IDH1 or -2 blocks osteoblast differentiation in vitro and in vivo

por Suijker, Johnny, Baelde, Hans J., Roelofs, Helene, Cleton-Jansen, Anne-Marie, Bovée, Judith V.M.G.
Publicado 2015

IDH mutations may not preclude distant, trans-tentorial spread in gliomas: a case report and review of the literature

por Hong, Christopher S., Hsieh, Jason K., Edwards, Nancy A., Ray-Chaudhury, Abhik, Zaghloul, Kareem A.
Publicado 2016

ATRX, IDH1-R132H and Ki-67 immunohistochemistry as a classification scheme for astrocytic tumors

por Cai, Jinquan, Zhang, Chuanbao, Zhang, Wei, Wang, Guangzhi, Yao, Kun, Wang, Zhiliang, Li, Guanzhang, Qian, Zenghui, Li, Yongli, Jiang, Tao, Jiang, Chuanlu
Publicado 2016

Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance

por Van Damme, Michaël, Crompot, Emerence, Meuleman, Nathalie, Maerevoet, Marie, Mineur, Philippe, Bron, Dominique, Lagneaux, Laurence, Stamatopoulos, Basile
Publicado 2016

Epigenetic silencing of XAF1 in high-grade gliomas is associated with IDH1 status and improved clinical outcome

por Reich, Thomas R., Switzeny, Olivier J., Renovanz, Mirjam, Sommer, Clemens, Kaina, Bernd, Christmann, Markus, Tomicic, Maja T.
Publicado 2017

Deep Learning based Radiomics (DLR) and its usage in noninvasive IDH1 prediction for low grade glioma

por Li, Zeju, Wang, Yuanyuan, Yu, Jinhua, Guo, Yi, Cao, Wei
Publicado 2017

IDH1 R132H Mutation Is Accompanied with Malignant Progression of Paired Primary-Recurrent Astrocytic Tumours

por Mu, Luyan, Xu, Wanzhen, Li, Qingla, Ge, Haitao, Bao, Hongbo, Xia, Songsong, Ji, Jingjing, Jiang, Jie, Song, Yuwen, Gao, Qiang
Publicado 2017

IDH2 deficiency increases the liver susceptibility to ischemia-reperfusion injury via increased mitochondrial oxidative injury

por Han, Sang Jun, Choi, Hong Seok, Kim, Jee In, Park, Jeen-Woo, Park, Kwon Moo
Publicado 2017

Diffusion tensor image features predict IDH genotype in newly diagnosed WHO grade II/III gliomas

por Eichinger, Paul, Alberts, Esther, Delbridge, Claire, Trebeschi, Stefano, Valentinitsch, Alexander, Bette, Stefanie, Huber, Thomas, Gempt, Jens, Meyer, Bernhard, Schlegel, Juergen, Zimmer, Claus, Kirschke, Jan S., Menze, Bjoern H., Wiestler, Benedikt
Publicado 2017

IDH1(R132H) is intrinsically tumor-suppressive but functionally attenuated by the glutamate-rich cerebral environment

por Tiburcio, Patricia D.B., Xiao, Bing, Chai, Yi, Asper, Sydney, Tripp, Sheryl R., Gillespie, David L., Jensen, Randy L., Huang, L. Eric
Publicado 2018

Multiregional radiomics profiling from multiparametric MRI: Identifying an imaging predictor of IDH1 mutation status in glioblastoma

por Li, Zhi‐Cheng, Bai, Hongmin, Sun, Qiuchang, Zhao, Yuanshen, Lv, Yanchun, Zhou, Jian, Liang, Chaofeng, Chen, Yinsheng, Liang, Dong, Zheng, Hairong
Publicado 2018

Integration of Radiomic and Multi-omic Analyses Predicts Survival of Newly Diagnosed IDH1 Wild-Type Glioblastoma

por Chaddad, Ahmad, Daniel, Paul, Sabri, Siham, Desrosiers, Christian, Abdulkarim, Bassam
Publicado 2019

Prediction of IDH Status Through MRI Features and Enlightened Reflection on the Delineation of Target Volume in Low-Grade Gliomas

por Ding, Haixia, Huang, Yong, Li, Zhiqiang, Li, Sirui, Chen, Qiongrong, Xie, Conghua, Zhong, Yahua
Publicado 2019

Somatic Mosaicism of IDH1 R132H Predisposes to Anaplastic Astrocytoma: A Case of Two Siblings

por Lee, Sulgi, Kambhampati, Madhuri, Almira-Suarez, M. Isabel, Ho, Cheng-Ying, Panditharatna, Eshini, Berger, Seth I., Turner, Joyce, Van Mater, David, Kilburn, Lindsay, Packer, Roger J., Myseros, John S., Vilain, Eric, Nazarian, Javad, Bornhorst, Miriam
Publicado 2020

Clinical pharmacokinetics and pharmacodynamics of ivosidenib, an oral, targeted inhibitor of mutant IDH1, in patients with advanced solid tumors

por Fan, Bin, Mellinghoff, Ingo K., Wen, Patrick Y., Lowery, Maeve A., Goyal, Lipika, Tap, William D., Pandya, Shuchi S., Manyak, Erika, Jiang, Liewen, Liu, Guowen, Nimkar, Tara, Gliser, Camelia, Prahl Judge, Molly, Agresta, Sam, Yang, Hua, Dai, David
Publicado 2019

The MRI Features and Prognosis of Gliomas Associated With IDH1 Mutation: A Single Center Study in Southwest China

por Shen, Guiquan, Wang, Rujia, Gao, Bo, Zhang, Zhongwen, Wu, Guipeng, Pope, Whitney
Publicado 2020